We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01527279
First Posted: February 7, 2012
Last Update Posted: May 22, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)